Report Detail

Request for Sample of this report

Pharma & Healthcare COVID-19 Impact on Global Biosimilars/Follow-on-Biologics, Market Insights and Forecast to 2026

  • RnM4079189
    • |
  • 25 June, 2020
    • |
  • Global
    • |
  • 119 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Biosimilars/Follow-on-Biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/Follow-on-Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biosimilars/Follow-on-Biologics market is segmented into
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others

Segment by Application, the Biosimilars/Follow-on-Biologics market is segmented into
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others

Regional and Country-level Analysis
The Biosimilars/Follow-on-Biologics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars/Follow-on-Biologics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars/Follow-on-Biologics Market Share Analysis
Biosimilars/Follow-on-Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars/Follow-on-Biologics business, the date to enter into the Biosimilars/Follow-on-Biologics market, Biosimilars/Follow-on-Biologics product introduction, recent developments, etc.
The major vendors covered:
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)


1 Study Coverage

  • 1.1 Biosimilars/Follow-on-Biologics Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Biosimilars/Follow-on-Biologics Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type
    • 1.4.2 Human growth hormone
    • 1.4.3 Erythropoietin
    • 1.4.4 Monoclonal antibodies
    • 1.4.5 Insulin
    • 1.4.6 Interferon
    • 1.4.7 Granulocyte-Colony Stimulating Factor
    • 1.4.8 Peptide
    • 1.4.9 Others
  • 1.5 Market by Application
    • 1.5.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Application
    • 1.5.2 Blood disorders
    • 1.5.3 Oncology diseases
    • 1.5.4 Chronic and autoimmune diseases
    • 1.5.5 Growth hormone deficiencies
    • 1.5.6 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Biosimilars/Follow-on-Biologics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Biosimilars/Follow-on-Biologics Industry
      • 1.6.1.1 Biosimilars/Follow-on-Biologics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Biosimilars/Follow-on-Biologics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Biosimilars/Follow-on-Biologics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Biosimilars/Follow-on-Biologics Market Size Estimates and Forecasts
    • 2.1.1 Global Biosimilars/Follow-on-Biologics Revenue 2015-2026
    • 2.1.2 Global Biosimilars/Follow-on-Biologics Sales 2015-2026
  • 2.2 Biosimilars/Follow-on-Biologics Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Biosimilars/Follow-on-Biologics Competitor Landscape by Players

  • 3.1 Biosimilars/Follow-on-Biologics Sales by Manufacturers
    • 3.1.1 Biosimilars/Follow-on-Biologics Sales by Manufacturers (2015-2020)
    • 3.1.2 Biosimilars/Follow-on-Biologics Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Biosimilars/Follow-on-Biologics Revenue by Manufacturers
    • 3.2.1 Biosimilars/Follow-on-Biologics Revenue by Manufacturers (2015-2020)
    • 3.2.2 Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Biosimilars/Follow-on-Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Biosimilars/Follow-on-Biologics Revenue in 2019
    • 3.2.5 Global Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Biosimilars/Follow-on-Biologics Price by Manufacturers
  • 3.4 Biosimilars/Follow-on-Biologics Manufacturing Base Distribution, Product Types
    • 3.4.1 Biosimilars/Follow-on-Biologics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Biosimilars/Follow-on-Biologics Product Type
    • 3.4.3 Date of International Manufacturers Enter into Biosimilars/Follow-on-Biologics Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
    • 4.1.1 Global Biosimilars/Follow-on-Biologics Sales by Type (2015-2020)
    • 4.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020)
    • 4.1.3 Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Biosimilars/Follow-on-Biologics Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2021-2026)
    • 4.2.3 Biosimilars/Follow-on-Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Biosimilars/Follow-on-Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
    • 5.1.1 Global Biosimilars/Follow-on-Biologics Sales by Application (2015-2020)
    • 5.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Application (2015-2020)
    • 5.1.3 Biosimilars/Follow-on-Biologics Price by Application (2015-2020)
  • 5.2 Biosimilars/Follow-on-Biologics Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Biosimilars/Follow-on-Biologics Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Biosimilars/Follow-on-Biologics by Country
    • 6.1.1 North America Biosimilars/Follow-on-Biologics Sales by Country
    • 6.1.2 North America Biosimilars/Follow-on-Biologics Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
  • 6.3 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Biosimilars/Follow-on-Biologics by Country
    • 7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Country
    • 7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
  • 7.3 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Biosimilars/Follow-on-Biologics by Region
    • 8.1.1 Asia Pacific Biosimilars/Follow-on-Biologics Sales by Region
    • 8.1.2 Asia Pacific Biosimilars/Follow-on-Biologics Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
  • 8.3 Asia Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Biosimilars/Follow-on-Biologics by Country
    • 9.1.1 Latin America Biosimilars/Follow-on-Biologics Sales by Country
    • 9.1.2 Latin America Biosimilars/Follow-on-Biologics Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
  • 9.3 Central & South America Biosimilars/Follow-on-Biologics Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Biosimilars/Follow-on-Biologics by Country
    • 10.1.1 Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Country
    • 10.1.2 Middle East and Africa Biosimilars/Follow-on-Biologics Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Type
  • 10.3 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description, Business Overview and Total Revenue
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
    • 11.1.5 Novartis Recent Development
  • 11.2 Synthon Pharmaceuticals
    • 11.2.1 Synthon Pharmaceuticals Corporation Information
    • 11.2.2 Synthon Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.2.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Products Offered
    • 11.2.5 Synthon Pharmaceuticals Recent Development
  • 11.3 Teva Pharmaceutical Industries
    • 11.3.1 Teva Pharmaceutical Industries Corporation Information
    • 11.3.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
    • 11.3.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Products Offered
    • 11.3.5 Teva Pharmaceutical Industries Recent Development
  • 11.4 LG Life Sciences
    • 11.4.1 LG Life Sciences Corporation Information
    • 11.4.2 LG Life Sciences Description, Business Overview and Total Revenue
    • 11.4.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 LG Life Sciences Biosimilars/Follow-on-Biologics Products Offered
    • 11.4.5 LG Life Sciences Recent Development
  • 11.5 Celltrion
    • 11.5.1 Celltrion Corporation Information
    • 11.5.2 Celltrion Description, Business Overview and Total Revenue
    • 11.5.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Celltrion Biosimilars/Follow-on-Biologics Products Offered
    • 11.5.5 Celltrion Recent Development
  • 11.6 Biocon
    • 11.6.1 Biocon Corporation Information
    • 11.6.2 Biocon Description, Business Overview and Total Revenue
    • 11.6.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Biocon Biosimilars/Follow-on-Biologics Products Offered
    • 11.6.5 Biocon Recent Development
  • 11.7 Hospira
    • 11.7.1 Hospira Corporation Information
    • 11.7.2 Hospira Description, Business Overview and Total Revenue
    • 11.7.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Hospira Biosimilars/Follow-on-Biologics Products Offered
    • 11.7.5 Hospira Recent Development
  • 11.8 Merck Group
    • 11.8.1 Merck Group Corporation Information
    • 11.8.2 Merck Group Description, Business Overview and Total Revenue
    • 11.8.3 Merck Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Merck Group Biosimilars/Follow-on-Biologics Products Offered
    • 11.8.5 Merck Group Recent Development
  • 11.9 Biogen idec, Inc.
    • 11.9.1 Biogen idec, Inc. Corporation Information
    • 11.9.2 Biogen idec, Inc. Description, Business Overview and Total Revenue
    • 11.9.3 Biogen idec, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Products Offered
    • 11.9.5 Biogen idec, Inc. Recent Development
  • 11.10 Genentech (Roche Group)
    • 11.10.1 Genentech (Roche Group) Corporation Information
    • 11.10.2 Genentech (Roche Group) Description, Business Overview and Total Revenue
    • 11.10.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Products Offered
    • 11.10.5 Genentech (Roche Group) Recent Development
  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description, Business Overview and Total Revenue
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
    • 11.1.5 Novartis Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Biosimilars/Follow-on-Biologics Market Estimates and Projections by Region
    • 12.1.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Biosimilars/Follow-on-Biologics Revenue Forecast by Regions 2021-2026
  • 12.2 North America Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
    • 12.2.1 North America: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
    • 12.2.2 North America: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
    • 12.2.3 North America: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
    • 12.3.2 Europe: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Biosimilars/Follow-on-Biologics Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Biosimilars/Follow-on-Biologics Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Biosimilars/Follow-on-Biologics Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Biosimilars/Follow-on-Biologics Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Biosimilars/Follow-on-Biologics Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Biosimilars/Follow-on-Biologics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Biosimilars/Follow-on-Biologics Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Biosimilars/Follow-on-Biologics. Industry analysis & Market Report on COVID-19 Impact on Global Biosimilars/Follow-on-Biologics is a syndicated market report, published as COVID-19 Impact on Global Biosimilars/Follow-on-Biologics, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biosimilars/Follow-on-Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,014.70
    		4,522.05
    		6,029.40
    		3,595.80
    		5,393.70
    		7,191.60
    		595,764.00
    		893,646.00
    		1,191,528.00
    		328,029.00
    		492,043.50
    		656,058.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo